Construction of eukaryotic expression plasmid of pcDNA3.1/VEGF-B-EGFP and its expression in bone marrow mesenchymal stem cells
Hui Wang
Abstract
Hui Wang
Abstract
Objective To detect the expression of vascular endothelial cell growth factor(VEGF)-B in human bone marrow mesenchymal stem cells(MSCs).Methods The recombinant plasmids of pcDNA 3.1/VEGF-B-EGFP were obtained by polymerase chain reaction(PCR) amplification,splicing,and insertion of complementary deoxyribonucleic acid(cDNA) fragments of VEGF-B and EGFP.The target gene was transferred to the third cultured MSCs(pcDNA 3.1/VEGF-B-EGFP transferred group) by using of cationic liposome mediated gene transfection technique.EGFP expression was detected with fluorescence microscopy,and the transfection rate was determined with flow cytometry.Reverse transcriptase PCR(RT-PCR),Western blot and other techniques were used to detect the expression of VEGF-B gene.Results In pcDNA 3.1/VEGF-B-EGFP transferred group,bright green fluorescence was observed with fluorescence microscopy 24 hours after transfection in MSCs,the rate of transfection analyzed with flow cytometry was 15%.RT-PCR results showed that the genome of VEGF-B transferred MSCs contained a 590bp specific fragment of VEGF-B gene.Western blot results proved VEGF-B protein expression in MSCs transferred by VEGF-B.Conclusion The generation of eukaryotic expression plasmid carrying VEGF-B gene and its expression in MSCs provide a sound basis for the combination of VEGF-B gene therapy and autologous MSCs transplantation in ischemic heart disease.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To detect the expression of vascular endothelial cell growth factor(VEGF)-B in human bone marrow mesenchymal stem cells(MSCs).Methods The recombinant plasmids of pcDNA 3.1/VEGF-B-EGFP were obtained by polymerase chain reaction(PCR) amplification,splicing,and insertion of complementary deoxyribonucleic acid(cDNA) fragments of VEGF-B and EGFP.The target gene was transferred to the third cultured MSCs(pcDNA 3.1/VEGF-B-EGFP transferred group) by using of cationic liposome mediated gene transfection technique.EGFP expression was detected with fluorescence microscopy,and the transfection rate was determined with flow cytometry.Reverse transcriptase PCR(RT-PCR),Western blot and other techniques were used to detect the expression of VEGF-B gene.Results In pcDNA 3.1/VEGF-B-EGFP transferred group,bright green fluorescence was observed with fluorescence microscopy 24 hours after transfection in MSCs,the rate of transfection analyzed with flow cytometry was 15%.RT-PCR results showed that the genome of VEGF-B transferred MSCs contained a 590bp specific fragment of VEGF-B gene.Western blot results proved VEGF-B protein expression in MSCs transferred by VEGF-B.Conclusion The generation of eukaryotic expression plasmid carrying VEGF-B gene and its expression in MSCs provide a sound basis for the combination of VEGF-B gene therapy and autologous MSCs transplantation in ischemic heart disease.
Key concepts: Molecular biology, Transfection, Mesenchymal stem cell, Flow cytometry, Green fluorescent protein, Vascular endothelial growth factor, Plasmid, Biology